EUVIMEDEUVIMED entdecken
ValidierungsstudieBeobachtungsstudieOpen Access · CC BY 4.0

The four-item PRECISE-DAPT score identifies coronary artery bypass grafting patients with increased risk for post-discharge major bleeding

Philip Enström, Andreas Martinsson, Mary Rezk, Susanne Nielsen, Erik Björklund, Maya Landenhed-Smith, Emily Pan iD, Anders Jeppsson

European Heart Journal - Cardiovascular Pharmacotherapy · 08.02.2025 · 11 (1) · 48-56

DOI: 10.1093/ehjcvp/pvae060 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Heart Journal - Cardiovascular Pharmacotherapy, online erschienen am 20.08.2024. Verfasst von Philip Enström und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg 41345, Sweden. Hauptthemen laut MEDLINE: Coronary Artery Bypass, Patient Discharge, Platelet Aggregation Inhibitors, Percutaneous Coronary Intervention. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swedish Heart-Lung Foundation, ALF, Västra Götalandsregionen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Early identification of patients with increased bleeding risk increases the possibility to individualize antithrombotic treatment. We validated the PRECISE-DAPT score, originally developed to estimate bleeding risk in patients on dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI), in coronary artery bypass grafting (CABG) patients. Methods and results All patients who underwent the first time, isolated CABG in Sweden 2009–2020 and survived until discharge were included. The four-item PRECISE-DAPT score, based on age, estimated glomerular filtration rate, pre-operative haemoglobin concentration, and previous spontaneous bleeding, was calculated in patients discharged on DAPT (n = 6838), or antiplatelet monotherapy (n = 15 406). High bleeding risk was defined as a score ≥25 in accordance with previous studies and major bleeding as hospitalization due to bleeding. Associations were assessed by C-statistics and Cox regression models. Major bleeding occurred during the first post-operative year in 130 patients (1.9%) in the DAPT group, and in 197 patients (1.3%) in the monotherapy group. The score identified 32.9% of the patients in the DAPT group and 38.2% in the monotherapy groups as having high bleeding risk. The area under the ROC-curve for the score was 0.67 (95%CI 0.62–0.72) for DAPT and 0.71 (0.67–0.74) for monotherapy. The hazard ratio for high bleeding risk vs. very low risk was 4.14 (2.07–8.26) for DAPT patients, and 4.95 (2.61–9.39) for monotherapy patients, both P < 0.001.

Conclusion

The PRECISE-DAPT identifies patients with increased risk for major bleeding after discharge following CABG with moderate accuracy. The accuracy is comparable to what previously has been reported for patients after PCI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery BypassPatient DischargePlatelet Aggregation InhibitorsPercutaneous Coronary InterventionPostoperative HemorrhageDual Anti-Platelet TherapyCoronary Artery DiseaseDecision Support TechniquesHemorrhageHumansMaleFemaleAgedRisk AssessmentRisk FactorsMiddle AgedSwedenTime FactorsTreatment OutcomePredictive Value of TestsReproducibility of ResultsRetrospective StudiesClinical Decision-Making

Stichwörter der Autor:innen

Antithrombotic treatmentBleeding complicationsCoronary artery bypass graftingDual anti platelet therapyPRECISE-DAPT score

Substanzen

Platelet Aggregation Inhibitors

Autor:innen und Institutionen

  • Department of Cardiothoracic Surgery, Sahlgrenska University Hospital, Gothenburg 41345, Sweden.
  • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg 41124, Sweden.
  • Department of Cardiology, Sahlgrenska University Hospital, Gothenburg 41345, Sweden.
  • Department of Medicine, Southern Älvborg Hospital, Borås 50182, Sweden.
  • Department of Surgery, Central Finland Hospital Nova, Jyväskylä 40630, Finland.

ORCID-Profile: Emily Pan

Förderung

  • Swedish Heart-Lung Foundation
  • ALF
  • Västra Götalandsregionen
  • Nils Winberg Family's Foundation

Zitieren

APA

Enström, P., Martinsson, A., Rezk, M., Nielsen, S., Björklund, E., Landenhed-Smith, M., Pan, E., & Jeppsson, A. (2025). The four-item PRECISE-DAPT score identifies coronary artery bypass grafting patients with increased risk for post-discharge major bleeding. European Heart Journal - Cardiovascular Pharmacotherapy, 11(1), 48-56. https://doi.org/10.1093/ehjcvp/pvae060

Vancouver

Enström P, Martinsson A, Rezk M, Nielsen S, Björklund E, Landenhed-Smith M, et al. The four-item PRECISE-DAPT score identifies coronary artery bypass grafting patients with increased risk for post-discharge major bleeding. European Heart Journal - Cardiovascular Pharmacotherapy. 2025;11(1):48-56. doi:10.1093/ehjcvp/pvae060

BibTeX
@article{Enstrm2025,
  author = {Enström, Philip and Martinsson, Andreas and Rezk, Mary and Nielsen, Susanne and Björklund, Erik and Landenhed-Smith, Maya and Pan, Emily and Jeppsson, Anders},
  title = {The four-item PRECISE-DAPT score identifies coronary artery bypass grafting patients with increased risk for post-discharge major bleeding},
  journal = {European Heart Journal - Cardiovascular Pharmacotherapy},
  year = {2025},
  volume = {11},
  number = {1},
  pages = {48--56},
  doi = {10.1093/ehjcvp/pvae060}
}
Kostenlos starten →